Also trades as: XTLB.TA (TLV) · $vol 0M
XTLB NASDAQ
XTL Biopharmaceuticals Ltd.
1W: -1.8%
1M: -18.8%
3M: -31.2%
YTD: +260.3%
1Y: +87.8%
3Y: +109.7%
5Y: -47.5%
$2.16
+0.03 (+1.41%)
Weekly Expected Move ±9.6%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.0M
52W Range2.01-10.28
Volume6,708
Avg Volume52,634
Beta0.45
Dividend—
Analyst Ratings
Company Info
CEONoam Band
Employees10
SectorHealthcare
IndustryBiotechnology
IPO Date2005-09-01
Websitextlbio.com
85 Medinat Hayehudim St.
Herzliya, TA 4676670
IL
Herzliya, TA 4676670
IL
972 3 611 6600
About XTL Biopharmaceuticals Ltd.
XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally established in 1993 as Xenograft Technologies Ltd., the company rebranded to XTL Biopharmaceuticals Ltd. in July 1995. It operates from its headquarters in Ramat Gan, Israel.
Latest News
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
Crude Oil Jumps 5%; Automatic Data Processing Posts Upbeat Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Segal Niv | 0 | — | 2026-03-18 | |
| EDELMAN JOSEPH | S-Sale | 9,600,000 | $0.15 | 2008-11-19 |
| EDELMAN JOSEPH | S-Sale | 24,681,360 | $0.14 | 2008-11-18 |
| EDELMAN JOSEPH | S-Sale | 2,696,450 | $0.15 | 2008-11-18 |
| EDELMAN JOSEPH | S-Sale | 29,740 | $0.16 | 2008-11-18 |